Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye

Allergan logo

Allergan

Status

Completed

Conditions

Dry Eye Syndrome

Treatments

Drug: Carboxymethylcellulose and Glycerin based artificial tear
Drug: Carboxymethylcellulose

Study type

Interventional

Funder types

Industry

Identifiers

NCT00514852
AG9818-002

Details and patient eligibility

About

The efficacy, safety and acceptability of a new artificial tear in subjects with dry eye will be compared to a currently-available artificial tear

Enrollment

316 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mild, moderate or Severe Symptoms of Dry Eye

Exclusion criteria

  • Uncontrolled systemic disease
  • Use of systemic medications affecting dry eye
  • Pregnancy or planning a pregnancy
  • Contact lens wear

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

316 participants in 2 patient groups

1
Experimental group
Description:
Carboxymethylcellulose and Glycerin based artificial tear
Treatment:
Drug: Carboxymethylcellulose and Glycerin based artificial tear
2
Active Comparator group
Description:
Carboxymethylcellulose
Treatment:
Drug: Carboxymethylcellulose

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems